Martin Friede
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- Viral gastroenteritis research and epidemiology 6
- Viral Infections and Outbreaks Research 6
- Epidemiology 24
- Influenza Virus Research Studies 16
- Respiratory viral infections research 6
- Co-authors
- Steven G. Reed (6 shared papers)Rhea N. Coler (5 shared papers)Sylvie Bertholet (2 shared papers)Christopher B. Fox (4 shared papers)Marie Paule Kiény (3 shared papers)Zarifah Reed (2 shared papers)Darrick Carter (2 shared papers)Thomas S. Vedvick (2 shared papers)
- Journals
- Vaccine (21 papers)Analytical Biochemistry (2 papers)The Lancet Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)Biologicals (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Martin Friede
51 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Immunology 954
- Infectious Diseases 653
- Pharmaceutical Science 181
- Epidemiology 848
- Virology 115
Countries citing papers authored by Martin Friede
This map shows the geographic impact of Martin Friede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Friede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Friede more than expected).
Fields of papers citing papers by Martin Friede
This network shows the impact of papers produced by Martin Friede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Friede. The network helps show where Martin Friede may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Friede, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New horizons in adjuvants for vaccine development Hit paper breakdown → | 2008 | 502 |
| 2 | 2011 | 250 | |
| 3 | 2011 | 134 | |
| 4 | 2002 | 125 | |
| 5 | 2010 | 110 | |
| 6 | 2006 | 107 | |
| 7 | 2009 | 91 | |
| 8 | 2021 | 85 | |
| 9 | 2017 | 84 | |
| 10 | 2008 | 80 | |
| 11 | 1993 | 73 | |
| 12 | 2011 | 71 | |
| 13 | 2010 | 51 | |
| 14 | 2004 | 50 | |
| 15 | 2018 | 49 | |
| 16 | 2018 | 46 | |
| 17 | 2016 | 46 | |
| 18 | 2018 | 46 | |
| 19 | 2009 | 45 | |
| 20 | 2007 | 41 |
About Martin Friede
Martin Friede is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Health and Immunology, having authored 52 papers that have together received 2.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (16 papers), Vaccine Coverage and Hesitancy (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Respiratory viral infections research (6 papers), Viral gastroenteritis research and epidemiology (6 papers), Viral Infections and Outbreaks Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Animal Disease Management and Epidemiology (5 papers). The work is most often cited by research in Immunology (954 citations), Infectious Diseases (653 citations), Pharmaceutical Science (181 citations), Epidemiology (848 citations) and Virology (115 citations). Martin Friede has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Steven G. Reed, Rhea N. Coler, Sylvie Bertholet, Christopher B. Fox, Marie Paule Kiény, Zarifah Reed, Darrick Carter, Thomas S. Vedvick, Marc Girard and Jean‐Paul Briand. Their work appears in journals such as Vaccine, Analytical Biochemistry, The Lancet Infectious Diseases, Clinical Infectious Diseases and Biologicals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.